The Microbiology Society has announced the finalists of the 2022 Sir Howard Dalton Young Microbiologist of the Year competition.
Molecular Pathology sector driven by research and rising use of high-throughput sequencing technologies
The global molecular diagnostics market size is expected to reach USD 50.94 Billion in 2030 and register a revenue CAGR of 12.4% over the forecast period, according to the latest report. The rising prevalence of infectious diseases and cancer is anticipated to fuel demand for molecular diagnostic tests.
The two new posts see an in-house microbiology laboratory established to accelerate the company’s product development.
PhoenixSoft’s Data Companion solution has been deployed at Milton Keynes University Hospital (MKUH) NHS Foundation Trust to provide enhanced and real-time access to pathology data to support performance monitoring and rapid response to ad hoc data queries.
Submissions are now open for the 2022 Lab Awards
Blackpool Teaching Hospitals received a VIP guest of honour early in August, when Dr Michael Osborn, president of The Royal College of Pathologists, officially opened the Trust’s new histopathology laboratory.
Unravelling of genetic mechanism behind tumour formation may improve targeted treatment for cancer patients
New research - published recently in Nature - offers new opportunities to improve diagnostics and targeted therapy for many cancer patients.
The two companies will work together to bring rapid antimicrobial identification and susceptibility diagnostics to more clinicians and patients worldwide.
The NHS in Lancashire and South Cumbria is set to pioneer the use of drone technology to deliver medical samples between selected hospital sites thanks to around £1.4m in UK Research and Innovation funding.
Medicines Discovery Catapult (MDC) and ZEISS have joined forces to improve drug discovery and early development of complex medicines by harnessing the power of advanced microscopy solutions.
Bio-Rad Laboratories has extended its range of StarBright dyes to include StarBright Violet 760, StarBright UltraViolet 575 and StarBright UltraViolet 605 dyes, offering improved brightness with narrow excitation and emission profiles.
‘Point of Care: Innovations’ is a free-to-attend meeting for NHS staff being held in Bristol at The Bristol – Harbourside (Doyle Collection) hotel on 20 September. Click on this item to access the confirmed programme.
Point-of-care testing has found application across the breadth of healthcare, a recent prime example being the role of viscoelastic POC testing in post-partum bleeding management in obstetrics.
Data from C2N Diagnostics shows that a blood test combining the Aβ42/40 ratio, a component of C2N’s PrecivityAD blood test, offers accuracy comparable to amyloid PET imaging and invasive CSF tests in identifying Alzheimer’s brain pathology.
A new College of American Pathologists (CAP) evidence-based guideline is among the first to address testing based less on the cancer type or tumour origin and more on the methodology and status of a biomarker.
The American Gastroenterological Association recently published a best practice advice article stating that the TissueCypher Barrett’s oesophagus test may be beneficial for risk-stratification in cases of non-dysplastic Barrett’s oesophagus (BE).
Thermo Fisher Scientific enables clinical research, toxicology and anti-doping laboratories performing dried spot sampling and analysis to utilise a new automated sample preparation and ultra-high-performance liquid chromatography (UHPLC) system.
San Paolo Hospital in Savona, Italy, has upgraded its Corelab-related analytical equipment. In collaboration with Beckman Coulter, the San Paolo diagnostic laboratory has installed Beckman Coulter's DxA 5000 Laboratory Automation System.